Endometriosis Trial, Recruiting

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

• Women who are pre-menopausal or in the perimenopause stage (the years leading up to menopause) who are attending a gynaecological ultrasound appointment and agree in writing to take part.
• Women who have symptoms related to their condition, as well as women who have no symptoms.
• Women using hormonal contraceptives (such as the pill or a coil) or hormone replacement therapy (HRT) may be included, but this information will be recorded.

Who may not be able to join:

• Women who have not signed a written consent form to take part in the study.
• Women who have a serious medical, psychiatric, or psychological condition that could affect their ability to make decisions about taking part.
• Women who have already gone through menopause.
• Women who are currently pregnant.
• Women who have previously had certain pelvic or bladder surgeries, such as a TVT (a procedure for bladder leakage) or mesh surgery.
• Women who have or have had cancer or pre-cancerous changes of the womb or cervix.
• Women who have previously had surgery to remove certain types of fibroids (specifically FIGO types 3–6).
• Women who have a blood clotting disorder and are currently taking blood-thinning medication.
• Women who have been told they have internal abdominal scarring (adhesions) from a previous surgery.
• Women who have previously been diagnosed with pelvic congestion syndrome (a condition causing chronic pelvic pain related to veins in the pelvis).
• Women with a psychiatric condition that would make it difficult to accurately report pain levels.
• Women who have previously had surgery or treatment for a severe form of endometriosis called deep infiltrating endometriosis (DIE).
• Women currently experiencing urinary problems such as pain when urinating, a strong sudden urge to urinate, or significant bladder leakage.
• Women with an active or ongoing pelvic infection (such as infection of the cervix, womb lining, fallopian tubes, or a severely inflamed pelvis).
• Women with cysts or other lesions on their ovaries.
• Women who show signs of deep infiltrating endometriosis on an ultrasound scan.
• Women with certain abnormalities inside the womb cavity, such as specific types of fibroids (FIGO types 0–2), polyps, internal scarring, or retained tissue following a pregnancy.
• Women with more than 3 small fibroids (each smaller than 2 cm in size) of FIGO types 3–8 — please note that having exactly 3 fibroids smaller than 2 cm does not exclude you (confirm with trial site).
• Women who have any fibroid larger than 2 cm.

Important: Always verify eligibility with the trial site directly before applying.